{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:11:03Z","timestamp":1780081863904,"version":"3.54.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.mayocp.2019.09.026","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T08:06:16Z","timestamp":1585728376000},"page":"669-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Specialty-Based Variability in Diagnosing and Managing Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"95","author":[{"given":"David T.","family":"Saxon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Guyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Konerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mayocp.2019.09.026_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.mayocp.2019.09.026_bib2","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/jama.296.18.2209","article-title":"Systolic and diastolic heart failure in the community","volume":"296","author":"Bursi","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.026_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.mayocp.2019.09.026_bib4","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.026_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCHEARTFAILURE.107.743146","article-title":"Death in heart failure: a community perspective","volume":"1","author":"Henkel","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.026_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehm554","article-title":"Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study","volume":"29","author":"Tribouilloy","year":"2008","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.026_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.112.972794","article-title":"Baseline characteristics of patients in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial","volume":"6","author":"Shah","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"17","key":"10.1016\/j.mayocp.2019.09.026_bib8","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.mayocp.2019.09.026_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/eurjhf\/hfr072","article-title":"Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction","volume":"13","author":"Hoekstra","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"27","key":"10.1016\/j.mayocp.2019.09.026_bib10","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.026_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.026_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cardfail.2004.10.006","article-title":"Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms","volume":"11","author":"Maurer","year":"2005","journal-title":"J\u00a0Card Fail"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.026_bib13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.026_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jacc.2006.08.050","article-title":"Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling\/dysfunction","volume":"49","author":"Melenovsky","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.026_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2012.05.014","article-title":"Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction","volume":"110","author":"Anjan","year":"2012","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.09.026_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.mayocp.2019.09.026_bib17","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9386","key":"10.1016\/j.mayocp.2019.09.026_bib18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.mayocp.2019.09.026_bib19","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.mayocp.2019.09.026_bib20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2019.09.026_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.mayocp.2019.09.026_bib22","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.amjcard.2018.01.027","article-title":"Discharge processes and 30-day readmission rates of patients hospitalized for heart failure on general medicine and cardiology services","volume":"121","author":"Salata","year":"2018","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.09.026_bib23","first-page":"194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"J AMA"},{"issue":"7","key":"10.1016\/j.mayocp.2019.09.026_bib24","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/euhj.1998.1057","article-title":"How to diagnose diastolic heart failure","volume":"19","year":"1998","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.mayocp.2019.09.026_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jacc.2011.02.054","article-title":"Heart failure with a preserved ejection fraction: what is in a name?","volume":"58","author":"Maurer","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.09.026_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/echo.13746","article-title":"Evolution of diastolic function algorithms: Implications for clinical practice","volume":"35","author":"Gottbrecht","year":"2018","journal-title":"Echocardiography"},{"issue":"1","key":"10.1016\/j.mayocp.2019.09.026_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mayocp.2019.09.026_bib28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A\u00a0simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2019.09.026_bib29","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.mayocp.2019.09.026_bib30","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2011.06.054","article-title":"Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study","volume":"58","author":"Edelmann","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.09.026_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/2047487314564729","article-title":"Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials","volume":"23","author":"Fukuta","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.09.026_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.mayocp.2019.09.026_bib33","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.jacc.2009.08.019","article-title":"Hospitalizations after heart failure diagnosis: a community perspective","volume":"54","author":"Dunlay","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.mayocp.2019.09.026_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11886-016-0802-1","article-title":"How to develop and implement a specialized heart failure with preserved ejection fraction clinical program","volume":"18","author":"Shah","year":"2016","journal-title":"Curr Cardiol Rep"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619308742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619308742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:32:41Z","timestamp":1758418361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619308742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0025619619308742"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.09.026","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specialty-Based Variability in Diagnosing and Managing Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}